These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 116791)

  • 21. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.
    Loeb HS; Ostrenga JP; Gaul W; Witt J; Freeman G; Scanlon P; Gunnar RM
    Circulation; 1983 Oct; 68(4):813-20. PubMed ID: 6413087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic properties of hydralazine in man.
    Gould L; Reddy CV; Zen B; Singh BK; Becker WH
    Pacing Clin Electrophysiol; 1980 Sep; 3(5):548-54. PubMed ID: 6160553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
    Korewicki J; Kraska T; Ostrzycki A; Opolski G
    Cor Vasa; 1985; 27(4):251-8. PubMed ID: 3931975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 29. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure?
    Haeusslein EA; Greenberg BH; Massie BM
    Chest; 1991 Nov; 100(5):1312-5. PubMed ID: 1935287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral hydralazine therapy for chronic refractory heart failure.
    Chatterjee K; Parmley WW; Massie B; Greenberg B; Werner J; Klausner S; Norman A
    Circulation; 1976 Dec; 54(6):879-83. PubMed ID: 825327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydralazine in the management of left ventricular failure.
    Fitchett DH; Neto JA; Oakley CM; Goodwin JF
    Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation.
    Roth A; Shotan A; Elkayam U
    Am Heart J; 1993 Jan; 125(1):155-63. PubMed ID: 8417512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure.
    Artman M; Parrish MD; Appleton S; Boucek RJ; Graham TP
    Am Heart J; 1987 Jan; 113(1):144-50. PubMed ID: 3799428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema.
    Bussmann WD; Kaltenbach M
    Eur J Cardiol; 1976 Sep; 4(3):327-33. PubMed ID: 823029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.